Figure 2.
BRCA1/2 testing for targeted therapies. PARPi: poly(ADP)ribose polymerase inhibitors. Not contributive: insufficient quantity of tumor cells or uninterpretable results.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.